On the afternoon of September 15th, local time in Germany, Ellesmere Zhu, the editor-in-chief of 2FIRSTS International, hosted an industry forum at the Dortmund Tobacco Exhibition with the theme "The Next Step for Harm Reduction Products". Experts in attendance engaged in lively discussions around the topic.
Attendees from left to right: Pei Chenxing (online), Fearon, Nussbaum, Aron, Zhu Hongxu | Source: 2FIRSTS
The forum was attended by experts from leading tobacco company PMI Germany, Dr. Alexander K. Nussbaum, Senior Aerosol Engineer at Smoore Testing Center, Dr. Pei Chenxing, General Manager of NGP Trends consulting firm, Aron Byrne Carter, and Dr. Ian Fearon, Chief Scientific Officer at McKinney Compliance and Public Health Consulting.
Ellesmere Zhu first provided a brief introduction to the background of Tobacco Harm Reduction (THR) and invited Aron and Pei Chenxing to give a brief overview of this concept. Subsequently, the discussion shifted to recent scientific research on THR, with Dr. Fearon and Dr. Nussbaum presenting their respective studies and findings. Dr. Nussbaum also pointed out that the biggest challenge currently facing the THR process stems from a lack of public awareness and understanding.
During the seminar, Dr. Fearon and Dr. Nussbaum shared their insights on how to advance the establishment of comprehensive and effective regulatory systems by governments and regulatory agencies in order to promote tobacco harm reduction. Dr. Fearon emphasized the importance of scientific collaboration between research institutions and regulatory bodies to inform policy-making and implementation with evidence-based practices. On the other hand, Dr. Nussbaum highlighted the need for the entire industry to unite with consumers in order to collectively submit recommendations to the government and drive regulation towards facilitating the development of less harmful tobacco products.
Finally, the participants also gave their opinions on the unity and cooperation within the entire tobacco harm reduction industry.
For further information about this forum, please stay tuned for upcoming reports from 2FIRSTS.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
